Emma Moore on October 30, 2026 8:56 am Silver leverage is strong here; beta cuts both ways though. Reply
Linda Jones on October 30, 2026 8:56 am Nice to see insider buying—usually a good signal in this space. Reply
Mary Moore on October 30, 2026 8:59 am Uranium names keep pushing higher—supply still tight into 2026. Reply
John V. Jackson on October 30, 2026 8:59 am I like the balance sheet here—less leverage than peers. Reply
Oliver Martinez on October 30, 2026 9:00 am I like the balance sheet here—less leverage than peers. Reply
Olivia Hernandez on October 30, 2026 9:00 am Interesting update on The CheyTac Intervention. Curious how the grades will trend next quarter. Reply
Olivia Thompson on October 30, 2026 9:00 am Nice to see insider buying—usually a good signal in this space. Reply
Isabella Taylor on October 30, 2026 9:01 am Interesting update on The CheyTac Intervention. Curious how the grades will trend next quarter. Reply
Mary Smith on October 30, 2026 9:01 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Olivia Johnson on October 30, 2026 9:02 am Production mix shifting toward Videos might help margins if metals stay firm. Reply
Mary Miller on October 30, 2026 9:02 am Nice to see insider buying—usually a good signal in this space. Reply
James T. Brown on October 30, 2026 9:03 am If AISC keeps dropping, this becomes investable for me. Reply
John Johnson on October 30, 2026 9:03 am Nice to see insider buying—usually a good signal in this space. Reply
Lucas Lopez on October 30, 2026 9:03 am Uranium names keep pushing higher—supply still tight into 2026. Reply
Amelia Taylor on October 30, 2026 9:07 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Lucas R. Jackson on October 30, 2026 9:07 am Silver leverage is strong here; beta cuts both ways though. Reply
Olivia White on October 30, 2026 9:09 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Oliver M. Rodriguez on October 30, 2026 9:11 am Interesting update on The CheyTac Intervention. Curious how the grades will trend next quarter. Reply
By Garand Thumb
By Garand Thumb
By Garand Thumb
36 Comments
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Interesting update on The CheyTac Intervention. Curious how the grades will trend next quarter.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Interesting update on The CheyTac Intervention. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Production mix shifting toward Videos might help margins if metals stay firm.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
If AISC keeps dropping, this becomes investable for me.
Nice to see insider buying—usually a good signal in this space.
Uranium names keep pushing higher—supply still tight into 2026.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Interesting update on The CheyTac Intervention. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.